Childhood cancer survivors have fewer long-term side effects: study

Better treatment strategies for pediatric cancers are helping survivors live longer, with fewer serious health problems related to their treatment, U.S. researchers said on Friday. The finding, presented at the American Society of Clinical Oncology meeting in Chicago, is based on analysis of data from 23,600 participants in the Childhood …

Read More »

Early use of J&J’s Zytiga extends prostate cancer survival

Adding Johnson & Johnson’s Zytiga to standard hormone therapy reduced by nearly 40 percent the chance of death for men newly diagnosed with high-risk prostate cancer that had spread to other parts of the body, according to new trial results. The data, which supports expanding the drug’s use to earlier …

Read More »

Early use of J&J’s Zytiga extends prostate cancer survival

Adding Johnson & Johnson’s Zytiga to standard hormone therapy reduced by nearly 40 percent the chance of death for men newly diagnosed with high-risk prostate cancer that had spread to other parts of the body, according to new trial results. The data, which supports expanding the drug’s use to earlier …

Read More »
error: Content is protected !!